Albireo Dashes Into PFIC Market As FDA, EMA Approve Bylvay

liver
Albireo is aiming to launch Bylvay immediately in the US, targeting around 100 physicians at 60 centers • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Rare Diseases

More from Scrip